{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:49:16Z","timestamp":1775058556279,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T00:00:00Z","timestamp":1395964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00404-014-3217-5","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T11:40:06Z","timestamp":1395920406000},"page":"321-328","source":"Crossref","is-referenced-by-count":33,"title":["Comparison of two oral contraceptive forms containing cyproterone acetate and drospirenone in the treatment of patients with polycystic ovary syndrome: a randomized clinical trial"],"prefix":"10.1007","volume":"290","author":[{"given":"Korhan","family":"Kahraman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yavuz Emre","family":"\u015e\u00fck\u00fcr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem Somer","family":"Atabeko\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Ate\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salih","family":"Ta\u015fk\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eerife Esra","family":"\u00c7etinkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harun Egemen","family":"Tolunay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Batuhan","family":"\u00d6zmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"S\u00f6nmezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00fclent","family":"Berker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,28]]},"reference":[{"key":"3217_CR1","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","volume":"84","author":"E Diamanti-Kandarakis","year":"1999","unstructured":"Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG et al (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbons: hormonal and metabolic profile. J Clin Endocrinol Metab 84:4006\u20134011","journal-title":"J Clin Endocrinol Metab"},{"key":"3217_CR2","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745\u20132749","journal-title":"J Clin Endocrinol Metab"},{"key":"3217_CR3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nrendo.2011.227","volume":"20","author":"A Dunaif","year":"2011","unstructured":"Dunaif A (2011) Polycystic ovary syndrome in 2011: genes, aging and sleep apnea in polycystic ovary syndrome. Nat Rev Endocrinol 20:72\u201374","journal-title":"Nat Rev Endocrinol"},{"key":"3217_CR4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1749-6632.2000.tb06236.x","volume":"900","author":"G Creatsas","year":"2000","unstructured":"Creatsas G, Koliopoulos C, Mastorakos G (2000) Combined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome. Lipid profile. Ann N Y Acad Sci 900:245\u2013252","journal-title":"Ann N Y Acad Sci"},{"key":"3217_CR5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bpobgyn.2004.05.004","volume":"18","author":"A Balen","year":"2004","unstructured":"Balen A (2004) The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology. Best Pract Res Clin Obstet Gynaecol 18:685\u2013706","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"3217_CR6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","volume":"38","author":"A Dunaif","year":"1989","unstructured":"Dunaif A, Segal KR, Futterweit W, Dobrjansky A (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165\u20131174","journal-title":"Diabetes"},{"key":"3217_CR7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM199608293350909","volume":"335","author":"RD Utiger","year":"1996","unstructured":"Utiger RD (1996) Insulin and the polycystic ovary syndrome. New Engl J Med 335:657\u2013658","journal-title":"New Engl J Med"},{"key":"3217_CR8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2265.1996.674495.x","volume":"44","author":"S Robinson","year":"1996","unstructured":"Robinson S, Henderson AD, Gelding SV, Kiddy D, Niththyananthan R, Bush A et al (1996) Dyslipidemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol Oxf 44:277\u2013284","journal-title":"Clin Endocrinol Oxf"},{"key":"3217_CR9","first-page":"275","volume":"98","author":"RA Wild","year":"1995","unstructured":"Wild RA (1995) Obesity, lipids, cardiovascular disease and androgen excess. Am J Med 98:275\u2013325","journal-title":"Am J Med"},{"key":"3217_CR10","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1210\/jcem-66-4-846","volume":"66","author":"G Kasdorf","year":"1988","unstructured":"Kasdorf G, Kalkhoff RK (1988) Prospective studies of insulin sensitivity in normal women receiving oral contraceptive agents. J Clin Endocrinol Metab 66:846\u2013852","journal-title":"J Clin Endocrinol Metab"},{"key":"3217_CR11","first-page":"64","volume":"74","author":"IF Godsland","year":"1992","unstructured":"Godsland IF, Walton C, Felton C, Proudler A, Patel A, Wynn V (1992) Insulin resistance, secretion and metabolism in users of oral contraception. J Clin Endocrinol Metab 74:64\u201370","journal-title":"J Clin Endocrinol Metab"},{"key":"3217_CR12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0015-0282(16)53212-9","volume":"53","author":"A Murphy","year":"1990","unstructured":"Murphy A, Cropp CS, Smith BS, Burkman RT, Zacur HA (1990) Effect of low dose oral contraceptive on gonadotrophins, androgens and sex hormone binding globulin in nonhirsute women. Fertil Steril 53:35\u201339","journal-title":"Fertil Steril"},{"key":"3217_CR13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ecl.2005.04.012","volume":"34","author":"PJ Hillard","year":"2005","unstructured":"Hillard PJ (2005) Oral contraceptives and the management of hyperandrogenism\u2014polycystic ovary syndrome in adolescents. Endocrinol Metab Clin North Am 34:707\u2013723","journal-title":"Endocrinol Metab Clin North Am"},{"key":"3217_CR14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ecl.2005.04.005","volume":"34","author":"C Buggs","year":"2005","unstructured":"Buggs C, Rosenfield RL (2005) Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin North Am 34:677\u2013705","journal-title":"Endocrinol Metab Clin North Am"},{"key":"3217_CR15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpobgyn.2004.05.007","volume":"18","author":"JS Archer","year":"2004","unstructured":"Archer JS, Chang RJ (2004) Hirsutism and acne in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:737\u2013754","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"3217_CR16","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewaily D, Diamanti-Kandarakis E, Escobar-Morreale HF, Hutterweit W (2006) Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91:4237\u20134245","journal-title":"J Clin Endocrinol Metab"},{"key":"3217_CR17","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0029-7844(02)02725-4","volume":"101","author":"R Azziz","year":"2003","unstructured":"Azziz R (2003) The evaluation and management of hirsutism. Obstet Gynecol 101:995\u20131007","journal-title":"Obstet Gynecol"},{"key":"3217_CR18","unstructured":"Hintze, J (2001) PASS 11. NCSS, LLC. Kaysville, Utah, USA. http:\/\/www.ncss.com"},{"key":"3217_CR19","volume-title":"Guidance for industry; acne vulgaris: developing drugs for treatment","author":"US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)","year":"2005","unstructured":"US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) (2005) Guidance for industry; acne vulgaris: developing drugs for treatment. Rockville, MD"},{"key":"3217_CR20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/09637480601137066","volume":"23","author":"C Batukan","year":"2007","unstructured":"Batukan C, Muderris II, Ozcelik B, Ozturk A (2007) Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism. Gynecol Endocrinol 23:38\u201344","journal-title":"Gynecol Endocrinol"},{"key":"3217_CR21","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jc.2007-2437","volume":"93","author":"KA Martin","year":"2008","unstructured":"Martin KA, Chang RJ, Ehrmann DA, Ibanez L, Lobo RA, Rosenfield RL et al (2008) Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:1105\u20131120","journal-title":"J Clin Endocrinol Metab"},{"key":"3217_CR22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/eje.0.1360339","volume":"136","author":"JJ Conn","year":"1997","unstructured":"Conn JJ, Jacobs HS (1997) The clinical management of hirsutism. Eur J Endocrinol 136:339\u2013348","journal-title":"Eur J Endocrinol"},{"key":"3217_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","volume":"62","author":"R Krattenmacher","year":"2000","unstructured":"Krattenmacher R (2000) Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception 62:29\u201338","journal-title":"Contraception"},{"key":"3217_CR24","first-page":"2559","volume":"80","author":"RS Rittmaster","year":"1995","unstructured":"Rittmaster RS (1995) Medical treatment of androgen-dependent hirsutism. J Clin Endocrinol Metab 80:2559\u20132563","journal-title":"J Clin Endocrinol Metab"},{"key":"3217_CR25","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2003-031158","volume":"89","author":"M Guido","year":"2004","unstructured":"Guido M, Romualdi D, Giuliani M, Suriano R, Selvaggi L, Apa R et al (2004) Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study. J Clin Endocrinol Metab 89:2817\u20132823","journal-title":"J Clin Endocrinol Metab"},{"key":"3217_CR26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.fertnstert.2012.06.035","volume":"98","author":"SM Bhattacharya","year":"2012","unstructured":"Bhattacharya SM, Jha A (2012) Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome. Fertil Steril 98:1053\u20131059","journal-title":"Fertil Steril"},{"key":"3217_CR27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.fertnstert.2005.07.1311","volume":"85","author":"C Batukan","year":"2006","unstructured":"Batukan C, Muderris II (2006) Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long term treatment of hirsutism. Fertil Steril 85:436\u2013440","journal-title":"Fertil Steril"},{"key":"3217_CR28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.contraception.2010.02.009","volume":"82","author":"A Kriplani","year":"2010","unstructured":"Kriplani A, Periyasamy AJ, Agarwal N, Kulshrestha V, Kumar A, Ammini AC (2010) Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome. Contraception 82:139\u2013146","journal-title":"Contraception"},{"key":"3217_CR29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0010-7824(90)90002-D","volume":"42","author":"L Falsetti","year":"1990","unstructured":"Falsetti L, Galbignani E (1990) Long-term treatment with the combination ethinyl estradiol and cyproterone acetate in polycystic ovary syndrome. Contraception 42:611\u2013619","journal-title":"Contraception"},{"key":"3217_CR30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1749-6632.1993.tb43875.x","volume":"687","author":"IM Golland","year":"1993","unstructured":"Golland IM, Elstein ME (1993) Results of an open one-year study with Diane-35 in women with polycystic ovarian syndrome. Ann N Y Acad Sci 687:263\u2013271","journal-title":"Ann N Y Acad Sci"},{"key":"3217_CR31","first-page":"12","volume":"63","author":"RH Wiebe","year":"1984","unstructured":"Wiebe RH, Morris CV (1984) Effect of an oral contraceptive on adrenal and ovarian androgenic steroids. Obstet Gynecol 63:12\u201314","journal-title":"Obstet Gynecol"},{"key":"3217_CR32","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2005.07.1306","volume":"85","author":"G Mastorakos","year":"2006","unstructured":"Mastorakos G, Koliopoulos C, Deligeoroglou E, Diamant-Kandarakis E, Creatsas G (2006) Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome. Fertil Steril 85:420\u2013427","journal-title":"Fertil Steril"},{"key":"3217_CR33","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1210\/jc.2003-030328","volume":"88","author":"A Cagnacci","year":"2003","unstructured":"Cagnacci A, Paoletti AM, Renzi A, Orru M, Pilloni M, Melis GB et al (2003) Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel. J Clin Endocrinol Metab 88:3621\u20133625","journal-title":"J Clin Endocrinol Metab"},{"key":"3217_CR34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/humrep\/deq301","volume":"26","author":"IJ Halperin","year":"2011","unstructured":"Halperin IJ, Kumar SS, Stroup DF, Laredo SE (2011) The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies. Hum Reprod 26:191\u2013201","journal-title":"Hum Reprod"},{"key":"3217_CR35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.OGX.0000109523.25076.E2","volume":"59","author":"RS Legro","year":"2004","unstructured":"Legro RS, Castracane VD, Kauffman RP (2004) Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 59:141\u2013154","journal-title":"Obstet Gynecol Surv"},{"key":"3217_CR36","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0015-0282(02)02993-X","volume":"77","author":"G Mastorakos","year":"2002","unstructured":"Mastorakos G, Koliopoulos C, Creatsas G (2002) Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives. Fertil Steril 77:919\u2013927","journal-title":"Fertil Steril"},{"key":"3217_CR37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.contraception.2004.12.005","volume":"71","author":"C Klipping","year":"2005","unstructured":"Klipping C, Marr J (2005) Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism. Contraception 71:409\u2013416","journal-title":"Contraception"},{"key":"3217_CR38","first-page":"1816","volume":"80","author":"W Oelkers","year":"1995","unstructured":"Oelkers W, Foidart JM, Dombrovicz N, Welter A, Heithecker R (1995) Effects of new oral contraceptive containing an antimineralocorticoid progestogen drospirenone on the rennin-aldosterone system, body weight, blood pressure, glucose tolerance and lipid metabolism. J Clin Endocrinol Metab 80:1816\u20131821","journal-title":"J Clin Endocrinol Metab"},{"key":"3217_CR39","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/AOG.0b013e31816a2476","volume":"111","author":"S Cauci","year":"2008","unstructured":"Cauci S, Di Santolo M, Culhane JF, Stel G, Gonano F, Guaschino S (2008) Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women. Obstet Gynecol 111:857\u2013864","journal-title":"Obstet Gynecol"},{"key":"3217_CR40","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/09513590.2010.530706","volume":"27","author":"S Kilic","year":"2011","unstructured":"Kilic S, Yilmaz N, Zulfikaroglu E, Erdogan G, Aydin M, Batioglu S (2011) Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment. Gynecol Endocrinol 27:622\u2013629","journal-title":"Gynecol Endocrinol"},{"key":"3217_CR41","first-page":"698","volume":"11","author":"V Norouzi","year":"2011","unstructured":"Norouzi V, Seifi M, Fallah S, Korani M, Samadikuchaksaraei A (2011) Effect of oral contraceptive therapy on homocysteine and C-reactive protein levels in women: an observational study. Anadolu Kardiyol Derg 11:698\u2013702","journal-title":"Anadolu Kardiyol Derg"},{"key":"3217_CR42","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.contraception.2005.09.011","volume":"73","author":"A Cagnacci","year":"2006","unstructured":"Cagnacci A, Tirelli A, Renzi A, Paoletti AM, Volpe A (2006) Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome. Contraception 73:348\u2013351","journal-title":"Contraception"},{"key":"3217_CR43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BCJM Fauser","year":"2012","unstructured":"Fauser BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R et al (2012) Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS consensus workshop group. Fertil Steril 97:28\u201338","journal-title":"Fertil Steril"},{"key":"3217_CR44","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1503\/cmaj.120677","volume":"185","author":"ST Bird","year":"2013","unstructured":"Bird ST, Hartzema AG, Brophy JM, Etminan M, Delaney JAC (2013) Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis. CMAJ 185:E115\u2013E120","journal-title":"CMAJ"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-014-3217-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-014-3217-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-014-3217-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:55:48Z","timestamp":1559066148000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-014-3217-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,28]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["3217"],"URL":"https:\/\/doi.org\/10.1007\/s00404-014-3217-5","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,28]]}}}